IL1B and metabolic syndrome: In patients with MetS, there are alterations in the antioxidant protection mechanisms and in the inflammatory process; for example, high concentrations of H2O2 decreased the gene expression of SOD and increased the levels of interleukin 1 beta (IL1β) in peripheral blood mononuclear cells (PBMCs) [179].